Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
Xiaorong Gu(Cleveland Clinic), Yogen Saunthararajah(Cleveland Clinic)
Cited by 117
Related Papers
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
|Blood|2011|100
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
|Journal of Clinical Investigation|2017|49
Noncytotoxic Differentiation Treatment of Renal Cell Cancer
|Cancer Research|2011|33